How much profit has Wai Yuen Tong Medicine Holdings made this year?
Wai Yuen Tong Medicine Holdings has made -15.36 M HKD this year.
Wai Yuen Tong Medicine Holdings Net Income 2024
Wai Yuen Tong Medicine Holdings Net Income
-15.36 M HKD
Ticker
897.HK
ISIN
BMG9421Y2332
In 2024, Wai Yuen Tong Medicine Holdings's profit amounted to -15.36 M HKD, a -25.15% increase from the -20.52 M HKD profit recorded in the previous year.
The Wai Yuen Tong Medicine Holdings Net Income history
| YEAR | NET INCOME (undefined HKD) |
|---|---|
| 2024 | -15.36 |
| 2023 | -20.52 |
| 2022 | -108.91 |
| 2021 | -376 |
| 2020 | 438.55 |
| 2019 | 74.63 |
| 2018 | -115.58 |
| 2017 | -93.3 |
| 2016 | 25.39 |
| 2015 | 120.98 |
| 2014 | 163.4 |
| 2013 | 148.4 |
| 2012 | -226.9 |
| 2011 | 99.1 |
| 2010 | 45.8 |
| 2009 | -345.9 |
| 2008 | 83.8 |
| 2007 | 9.9 |
| 2006 | -98.4 |
| 2005 | -67 |
Wai Yuen Tong Medicine Holdings Revenue, EBIT, Net Income BMG9421Y2332 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Wai Yuen Tong Medicine Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Wai Yuen Tong Medicine Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Wai Yuen Tong Medicine Holdings’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Wai Yuen Tong Medicine Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Wai Yuen Tong Medicine Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Wai Yuen Tong Medicine Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Wai Yuen Tong Medicine Holdings’s growth potential.
Wai Yuen Tong Medicine Holdings Revenue, EBIT and net profit per share
| Date | Wai Yuen Tong Medicine Holdings Revenue | Wai Yuen Tong Medicine Holdings EBIT | Wai Yuen Tong Medicine Holdings Net Income |
|---|---|---|---|
| 2024 | 783.88 M undefined | 48.84 M undefined | -15.36 M undefined |
| 2023 | 723.6 M undefined | 11.25 M undefined | -20.52 M undefined |
| 2022 | 1.39 B undefined | 118.58 M undefined | -108.91 M undefined |
| 2021 | 1.11 B undefined | 40.72 M undefined | -376 M undefined |
| 2020 | 620.74 M undefined | -114.63 M undefined | 438.55 M undefined |
| 2019 | 751.44 M undefined | -129.82 M undefined | 74.63 M undefined |
| 2018 | 845.78 M undefined | -97.7 M undefined | -115.58 M undefined |
| 2017 | 738.44 M undefined | -23.44 M undefined | -93.3 M undefined |
| 2016 | 825.33 M undefined | 15.97 M undefined | 25.39 M undefined |
| 2015 | 831.09 M undefined | -53.33 M undefined | 120.98 M undefined |
| 2014 | 865.3 M undefined | 28.3 M undefined | 163.4 M undefined |
| 2013 | 808.5 M undefined | 25.8 M undefined | 148.4 M undefined |
| 2012 | 752.1 M undefined | 49.8 M undefined | -226.9 M undefined |
| 2011 | 639.5 M undefined | 25.2 M undefined | 99.1 M undefined |
| 2010 | 529.3 M undefined | 16.8 M undefined | 45.8 M undefined |
| 2009 | 496.2 M undefined | -17 M undefined | -345.9 M undefined |
| 2008 | 477 M undefined | 1.1 M undefined | 83.8 M undefined |
| 2007 | 381.3 M undefined | -3 M undefined | 9.9 M undefined |
| 2006 | 324.8 M undefined | -40.6 M undefined | -98.4 M undefined |
| 2005 | 326.9 M undefined | -19 M undefined | -67 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 326.9 M HKD | -19 M HKD | -67 M HKD |
| 2006 | 324.8 M HKD | -40.6 M HKD | -98.4 M HKD |
| 2007 | 381.3 M HKD | -3 M HKD | 9.9 M HKD |
| 2008 | 477 M HKD | 1.1 M HKD | 83.8 M HKD |
| 2009 | 496.2 M HKD | -17 M HKD | -345.9 M HKD |
| 2010 | 529.3 M HKD | 16.8 M HKD | 45.8 M HKD |
| 2011 | 639.5 M HKD | 25.2 M HKD | 99.1 M HKD |
| 2012 | 752.1 M HKD | 49.8 M HKD | -226.9 M HKD |
| 2013 | 808.5 M HKD | 25.8 M HKD | 148.4 M HKD |
| 2014 | 865.3 M HKD | 28.3 M HKD | 163.4 M HKD |
| 2015 | 831.09 M HKD | -53.33 M HKD | 120.98 M HKD |
| 2016 | 825.33 M HKD | 15.97 M HKD | 25.39 M HKD |
| 2017 | 738.44 M HKD | -23.44 M HKD | -93.3 M HKD |
| 2018 | 845.78 M HKD | -97.7 M HKD | -115.58 M HKD |
| 2019 | 751.44 M HKD | -129.82 M HKD | 74.63 M HKD |
| 2020 | 620.74 M HKD | -114.63 M HKD | 438.55 M HKD |
| 2021 | 1.11 B HKD | 40.72 M HKD | -376 M HKD |
| 2022 | 1.39 B HKD | 118.58 M HKD | -108.91 M HKD |
| 2023 | 723.6 M HKD | 11.25 M HKD | -20.52 M HKD |
| 2024 | 783.88 M HKD | 48.84 M HKD | -15.36 M HKD |
Wai Yuen Tong Medicine Holdings stock margins BMG9421Y2332 ·
The Wai Yuen Tong Medicine Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Wai Yuen Tong Medicine Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Wai Yuen Tong Medicine Holdings.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Wai Yuen Tong Medicine Holdings's sales revenue. A higher gross margin percentage indicates that the Wai Yuen Tong Medicine Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Wai Yuen Tong Medicine Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Wai Yuen Tong Medicine Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Wai Yuen Tong Medicine Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Wai Yuen Tong Medicine Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Wai Yuen Tong Medicine Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Wai Yuen Tong Medicine Holdings Margin History
| Wai Yuen Tong Medicine Holdings Gross margin | Wai Yuen Tong Medicine Holdings Profit margin | Wai Yuen Tong Medicine Holdings EBIT margin | Wai Yuen Tong Medicine Holdings Profit margin |
|---|---|---|---|
| 2024 | 50.37 % | 6.23 % | -1.96 % |
| 2023 | 47.31 % | 1.55 % | -2.84 % |
| 2022 | 40.99 % | 8.52 % | -7.83 % |
| 2021 | 39.6 % | 3.67 % | -33.92 % |
| 2020 | 45.36 % | -18.47 % | 70.65 % |
| 2019 | 40.13 % | -17.28 % | 9.93 % |
| 2018 | 40.65 % | -11.55 % | -13.67 % |
| 2017 | 42.08 % | -3.17 % | -12.64 % |
| 2016 | 44.86 % | 1.93 % | 3.08 % |
| 2015 | 42.24 % | -6.42 % | 14.56 % |
| 2014 | 45.01 % | 3.27 % | 18.88 % |
| 2013 | 45.18 % | 3.19 % | 18.35 % |
| 2012 | 47.12 % | 6.62 % | -30.17 % |
| 2011 | 47.16 % | 3.94 % | 15.5 % |
| 2010 | 47.69 % | 3.17 % | 8.65 % |
| 2009 | 46.09 % | -3.43 % | -69.71 % |
| 2008 | 46.42 % | 0.23 % | 17.57 % |
| 2007 | 45.97 % | -0.79 % | 2.6 % |
| 2006 | 41.23 % | -12.5 % | -30.3 % |
| 2005 | 50.41 % | -5.81 % | -20.5 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 50.41 % | -5.81 % | -20.5 % |
| 2006 | 41.23 % | -12.5 % | -30.3 % |
| 2007 | 45.97 % | -0.79 % | 2.6 % |
| 2008 | 46.42 % | 0.23 % | 17.57 % |
| 2009 | 46.09 % | -3.43 % | -69.71 % |
| 2010 | 47.69 % | 3.17 % | 8.65 % |
| 2011 | 47.16 % | 3.94 % | 15.5 % |
| 2012 | 47.12 % | 6.62 % | -30.17 % |
| 2013 | 45.18 % | 3.19 % | 18.35 % |
| 2014 | 45.01 % | 3.27 % | 18.88 % |
| 2015 | 42.24 % | -6.42 % | 14.56 % |
| 2016 | 44.86 % | 1.93 % | 3.08 % |
| 2017 | 42.08 % | -3.17 % | -12.64 % |
| 2018 | 40.65 % | -11.55 % | -13.67 % |
| 2019 | 40.13 % | -17.28 % | 9.93 % |
| 2020 | 45.36 % | -18.47 % | 70.65 % |
| 2021 | 39.6 % | 3.67 % | -33.92 % |
| 2022 | 40.99 % | 8.52 % | -7.83 % |
| 2023 | 47.31 % | 1.55 % | -2.84 % |
| 2024 | 50.37 % | 6.23 % | -1.96 % |
Wai Yuen Tong Medicine Holdings Aktienanalyse
What does Wai Yuen Tong Medicine Holdings do?
Wai Yuen Tong Medicine Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Wai Yuen Tong Medicine Holdings's Profit Margins
The profit margins of Wai Yuen Tong Medicine Holdings represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Wai Yuen Tong Medicine Holdings's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Wai Yuen Tong Medicine Holdings's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Wai Yuen Tong Medicine Holdings's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Wai Yuen Tong Medicine Holdings’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Wai Yuen Tong Medicine Holdings stock
How has the profit developed compared to last year?
The profit has increased by -25.15% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Wai Yuen Tong Medicine Holdings publish its earnings?
Wai Yuen Tong Medicine Holdings publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Wai Yuen Tong Medicine Holdings?
The profits of Wai Yuen Tong Medicine Holdings are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Wai Yuen Tong Medicine Holdings?
You can learn more about the earnings of Wai Yuen Tong Medicine Holdings by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Wai Yuen Tong Medicine Holdings pay?
Over the past 12 months, Wai Yuen Tong Medicine Holdings paid a dividend of 0.15 HKD . This corresponds to a dividend yield of about 77.37 %. For the coming 12 months, Wai Yuen Tong Medicine Holdings is expected to pay a dividend of 0.15 HKD.
What is the dividend yield of Wai Yuen Tong Medicine Holdings?
The current dividend yield of Wai Yuen Tong Medicine Holdings is 77.37 %.
When does Wai Yuen Tong Medicine Holdings pay dividends?
Wai Yuen Tong Medicine Holdings pays a quarterly dividend. This is distributed in the months of September, September, August, September.
How secure is the dividend of Wai Yuen Tong Medicine Holdings?
Wai Yuen Tong Medicine Holdings paid dividends every year for the past 1 years.
What is the dividend of Wai Yuen Tong Medicine Holdings?
For the upcoming 12 months, dividends amounting to 0.15 HKD are expected. This corresponds to a dividend yield of 77.37 %.
In which sector is Wai Yuen Tong Medicine Holdings located?
Wai Yuen Tong Medicine Holdings is assigned to the 'Health' sector.
Wann musste ich die Aktien von Wai Yuen Tong Medicine Holdings kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Wai Yuen Tong Medicine Holdings from 9/6/2024 amounting to 0.147 HKD, you needed to have the stock in your portfolio before the ex-date on 8/22/2024.
When did Wai Yuen Tong Medicine Holdings pay the last dividend?
The last dividend was paid out on 9/6/2024.
What was the dividend of Wai Yuen Tong Medicine Holdings in the year 2023?
In the year 2023, Wai Yuen Tong Medicine Holdings distributed 0 HKD as dividends.
In which currency does Wai Yuen Tong Medicine Holdings pay out the dividend?
The dividends of Wai Yuen Tong Medicine Holdings are distributed in HKD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Wai Yuen Tong Medicine Holdings
Our stock analysis for Wai Yuen Tong Medicine Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Wai Yuen Tong Medicine Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Wai Yuen Tong Medicine Holdings Revenue
- Wai Yuen Tong Medicine Holdings Net Income
- Wai Yuen Tong Medicine Holdings P/E
- Wai Yuen Tong Medicine Holdings P/S
- Wai Yuen Tong Medicine Holdings EBIT
- Wai Yuen Tong Medicine Holdings Dividend
- Wai Yuen Tong Medicine Holdings Stocks
- Wai Yuen Tong Medicine Holdings Market capitalization
- Wai Yuen Tong Medicine Holdings Debt
- Wai Yuen Tong Medicine Holdings Liabilities
- Wai Yuen Tong Medicine Holdings Equity
- Wai Yuen Tong Medicine Holdings AAQS
- Wai Yuen Tong Medicine Holdings Employees
- Wai Yuen Tong Medicine Holdings ROE
- Wai Yuen Tong Medicine Holdings ROA
- Wai Yuen Tong Medicine Holdings ROCE